Company profilePharmaceutical#82 of 1,318 in Pakistan✓ No DRAP alerts

XENON PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 187 brands · 161 molecules

Ranked #50 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

187 registered products 40 pharmaceutical brands 161 distinct molecules 0 DRAP alerts

Company overview

187
registered products
40
pharmaceutical brands
161
distinct molecules
12
therapeutic classes
0
DRAP alerts

XENON PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 187 product registrations across 161 distinct molecules. It is the 82nd largest registrant in Pakistan by product count, and ranks 50th of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by XENON

56 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 2
Anti-Parkinson Drugs 1
Antifungal For Dermatological 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

52
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202652

Top molecules by brand count

Nutritional Supplement / Multivitamin21 brands
Paracetamol6 brands
Omeprazole4 brands
Trimethoprim3 brands
Risperidone3 brands
Ondansetron3 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 6Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 4Antianemic, Iron Preparations · 3Blood Glucose Lowering Drugs, Excluding Insulin · 2Lipid Modifying Agents · 1Neuro · 1Antiemetics & Antinauseants · 1Cardiac Therapy · 1Antibiotics For Topical Use · 1Drugs For Constipation · 1Vitamin B Complex Plain & With Vitamin C · 1Nasal Preparations · 1

Conditions treated

Epilepsy/Convulsion · 1Eczema/Psoriasis/Dermatitis · 1Nasal Congestion · 1Hormonal Therapy · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official107 products · Rs 25.38 – Rs 12,945.2
DVAGO2 products · Rs 60.25 – Rs 251
Servaid5 products · Rs 21.87 – Rs 103.75
Median across source: Rs 155.62

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 115 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
NEUTRO PHARMA (PVT) LTD. holds 105 molecules not in this portfolio
AcetylcysteineAcyclovirAmikacinAnastrazoleAnastrozoleAntimony
Atco Pharma International (Pvt) Ltd holds 212 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAminophyllineAmlodipine

Get the full profile for XENON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.